AMBI Insider Trading Activity and SEC Form 4 Filings
AMBI insider trading summary
No open-market insider purchases or sales of Ambit Biosciences Corp (AMBI) have been reported on SEC Form 4 in the past 12 months.
Latest AMBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 24, 2013 | Foresite Capital Fund I, L.P. | 10% Owner | Buy | $33K (4,817 @ $6.77) |
| Jun 24, 2013 | Foresite Capital Management I, LLC | 10% Owner | Buy | $33K (4,817 @ $6.77) |
| Jun 24, 2013 | James B. Tananbaum | 10% Owner | Buy | $33K (4,817 @ $6.77) |
| Jun 14, 2013 | Foresite Capital Management I, LLC | 10% Owner | Buy | $56K (7,500 @ $7.46) |
| Jun 14, 2013 | Foresite Capital Fund I, L.P. | 10% Owner | Buy | $56K (7,500 @ $7.46) |
| Jun 14, 2013 | James B. Tananbaum | 10% Owner | Buy | $56K (7,500 @ $7.46) |
| Jun 12, 2013 | Foresite Capital Fund I, L.P. | 10% Owner | Buy | $42K (5,700 @ $7.45) |
| Jun 12, 2013 | Foresite Capital Management I, LLC | 10% Owner | Buy | $42K (5,700 @ $7.45) |
| Jun 12, 2013 | James B. Tananbaum | 10% Owner | Buy | $42K (5,700 @ $7.45) |
| Jun 3, 2013 | James B. Tananbaum | 10% Owner | Buy | $70K (10,000 @ $6.99) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.